KaydedilenlerDerginizi ekleyin

Dergiler / Journal of Surgery and Medicine / 2021 / Cilt: 5 - Sayı: 11

Effects of cranial nerve blockage in patients with chronic migraine resistant to first-line treatment

Gökhan EVCİLİ
Ahmet YABALAK
Sayfa
1131–1134
Yayın Tarihi
2021-11-01
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Results: The second-month VAS scores and the number of days in pain were significantly lower than baseline in both the CNB and control groups (P

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/Aim: Migraine is a common, disabling neurological disorder and cranial nerve blocks (CNB) are used in the treatment of headaches.
📊
Temel Bulgular & Veri:Methods: This retrospective cohort study included 102 patients with chronic migraine resistant to first-line treatment who were treated in our outpatient clinic.
💡
Sonuç & Katkı:Results: The second-month VAS scores and the number of days in pain were significantly lower than baseline in both the CNB and control groups (P
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Chronic migraine · Nerve block · Great occipital nerve

Abstract

Background/Aim: Migraine is a common, disabling neurological disorder and cranial nerve blocks (CNB) are used in the treatment of headaches. This study aimed to compare the effectiveness of a CNB with conventional medical treatment in patients with chronic migraine resistant to first-line treatment. Methods: This retrospective cohort study included 102 patients with chronic migraine resistant to first-line treatment who were treated in our outpatient clinic. The patients were divided into two groups as those who underwent CNB (n=67) and the control group, who were only treated with conventional drugs (n=35). Bilateral CNB was performed on the patients at baseline and in the second week. The patients’ Visual Analogue Scale (VAS) scores, number of days in pain, and the number of analgesics taken were recorded at baseline and the second month. Results: The second-month VAS scores and the number of days in pain were significantly lower than baseline in both the CNB and control groups (P

🔖

Bu Makaleye Atıf Yap

EVCİLİ, G., YABALAK, A. (2021). Effects of cranial nerve blockage in patients with chronic migraine resistant to first-line treatment. Journal of Surgery and Medicine, Cilt: 5 - Sayı: 11, 1131–1134. https://ajindex.com/articles/779801

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (3)

  1. Stewart WF, Shechter A, Rasmussen B. Migraine prevalence. A review of population-based studies. Neurology. 1994;44(6 Suppl 4):S17-23
  2. Ertas M, Baykan B, Orhan EK, Zarifoglu M, Karli N, Saip S, et al. One-year prevalence and the impact of migraine and tension-type headache in Turkey: a nationwide home-based study in adults. J Headache Pain. 2012;13(2):147-57. doi: 10.1007/s10194-011-0414-5 3. Ha H, Gonzalez A. Migraine Headache Prophylaxis. American family physician. 2019;99(1):17-24
  3. Blumenfeld AM, Bloudek LM, Becker WJ, Buse DC, Varon SF, Maglinte GA, et al. Patterns of use and reasons for discontinuation of prophylactic medications for episodic migraine and chronic migraine: Results from the second International Burden of Migraine Study (IBMS‐II). Headache: The Journal of Head and Face Pain. 2013;53(4):644-55. doi: 10.1111/head.12055 5. Blumenfeld A, Ashkenazi A, Napchan U, Bender SD, Klein BC, Berliner R, et al. Expert Consensus Recommendations for the Performance of Peripheral Nerve Blocks for Headaches – A Narrative Review. Headache: The Journal of Head and Face Pain. 2013;53(3):437-46. doi: 10.1111/head.12053 6. Terzi T, Karakurum B, Üçler S, İnan LE, Tulunay C. Greater occipital nerve blockade in migraine, tension-type headache and cervicogenic headache. J Headache Pain. 2002;3(3):137-41. doi: 10.1007/s101940200031 7. Ashkenazi A, Young WB. The Effects of Greater Occipital Nerve Block and Trigger Point Injection on Brush Allodynia and Pain in Migraine. Headache: The Journal of Head and Face Pain. 2005;45(4):350-4. doi: 10.1111/j.1526-4610.2005.05073.x 8. Inan N, Inan LE, Coşkun Ö, Tunç T, Ilhan M. Effectiveness of Greater Occipital Nerve Blocks in Migraine Prophylaxis. Noro Psikiyatr Ars. 2016;53(1):45-8. doi: 10.5152/npa.2015.10003 9. Tang Y, Kang J, Zhang Y, Zhang X. Influence of greater occipital nerve block on pain severity in migraine patients: A systematic review and meta-analysis. The American Journal of Emergency Medicine. 2017;35(11):1750-4. doi: 10.1016/j.ajem.2017.08.027 10. Zhang H, Yang X, Lin Y, Chen L, Ye H. The efficacy of greater occipital nerve block for the treatment of migraine: A systematic review and meta-analysis. Clinical Neurology and Neurosurgery. 2018;165:129-33. doi: 10.1016/j.clineuro.2017.12.026 11. Caputi CA, Firetto V. Therapeutic Blockade of Greater Occipital and Supraorbital Nerves in Migraine Patients. Headache: The Journal of Head and Face Pain. 1997;37(3):174-9. doi: 10.1046/j.1526-4610.1997.3703174.x 12